Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating encouraging results in the management of type 2 diabetes. This synthetic peptide resembles the actions of naturally produced GLP-1, a https://45listing.com/story22959926/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes